Takara Bio Inc

TSE:4974 (Japan)   Ordinary Shares
円 1034.00 (+1.08%) Jun 3
84.15
P/B:
1.11
Market Cap:
円 124.51B ($ 803.97M)
Enterprise V:
円 90.06B ($ 581.53M)
Volume:
160.00K
Avg Vol (2M):
255.29K
Also Trade In:
Volume:
160.00K
Avg Vol (2M):
255.29K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Takara Bio Inc ( ) from 2004 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Takara Bio stock (TSE:4974) PE ratio as of Jun 04 2024 is 84.15. More Details

Takara Bio Inc (TSE:4974) PE Ratio (TTM) Chart

To

Takara Bio Inc (TSE:4974) PE Ratio (TTM) Historical Data

Total 1231
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Takara Bio PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-04 84.1 2024-03-28 79.3
2024-06-03 84.1 2024-03-27 75.5
2024-05-31 83.3 2024-03-26 75.3
2024-05-30 81.6 2024-03-25 75.9
2024-05-29 81.6 2024-03-22 77.5
2024-05-28 83.9 2024-03-21 77.1
2024-05-27 84.3 2024-03-19 77.2
2024-05-24 83.1 2024-03-18 77.5
2024-05-23 84.3 2024-03-15 75.6
2024-05-22 88.5 2024-03-14 77.5
2024-05-21 88.9 2024-03-13 76.6
2024-05-20 88.1 2024-03-12 77.2
2024-05-17 88.4 2024-03-11 76.7
2024-05-16 89.4 2024-03-08 77.2
2024-05-15 88.5 2024-03-07 77.5
2024-05-14 86.3 2024-03-06 77.4
2024-05-13 84.5 2024-03-05 75.9
2024-05-10 83.4 2024-03-04 75.8
2024-05-09 83.0 2024-03-01 76.6
2024-05-08 82.3 2024-02-29 77.9
2024-05-07 82.4 2024-02-28 80.1
2024-05-02 82.2 2024-02-27 79.1
2024-05-01 82.6 2024-02-26 79.4
2024-04-30 83.2 2024-02-22 79.2
2024-04-26 82.6 2024-02-21 80.6
2024-04-25 82.5 2024-02-20 83.3
2024-04-24 82.9 2024-02-19 82.0
2024-04-23 82.0 2024-02-16 80.8
2024-04-22 80.5 2024-02-15 78.5
2024-04-19 77.8 2024-02-14 91.4
2024-04-18 78.5 2024-02-13 91.8
2024-04-17 78.0 2024-02-09 91.3
2024-04-16 79.0 2024-02-08 92.3
2024-04-15 77.6 2024-02-07 94.2
2024-04-12 78.7 2024-02-06 93.3
2024-04-11 78.4 2024-02-05 95.2
2024-04-10 78.7 2024-02-02 95.5
2024-04-09 77.6 2024-02-01 95.2
2024-04-08 78.1 2024-01-31 96.6
2024-04-05 78.1 2024-01-30 97.9
2024-04-04 76.7 2024-01-29 97.4
2024-04-03 76.7 2024-01-26 96.2
2024-04-02 76.6 2024-01-25 95.3
2024-04-01 78.6 2024-01-24 95.2
2024-03-29 79.3 2024-01-23 94.5

Takara Bio Inc (TSE:4974) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.